1.Wolffian adnexal tumor: report of a case.
Ren-qiao LIU ; Zhen-huan ZHANG ; Min-hong PAN ; Zhi-hong ZHANG ; Qin-he FAN
Chinese Journal of Pathology 2013;42(7):476-477
Adenoma
;
metabolism
;
pathology
;
surgery
;
ultrastructure
;
Adnexa Uteri
;
pathology
;
surgery
;
Adnexal Diseases
;
metabolism
;
pathology
;
surgery
;
Carcinoma, Endometrioid
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Female
;
Granulosa Cell Tumor
;
metabolism
;
pathology
;
Humans
;
Hysterectomy
;
Keratins
;
metabolism
;
Leiomyomatosis
;
pathology
;
surgery
;
Microscopy, Electron
;
Middle Aged
;
Neoplasms, Multiple Primary
;
metabolism
;
pathology
;
surgery
;
ultrastructure
;
Sertoli-Leydig Cell Tumor
;
metabolism
;
pathology
;
Uterine Neoplasms
;
pathology
;
surgery
;
Vimentin
;
metabolism
;
WT1 Proteins
;
metabolism
2.Ovarian-colonic fistula caused by endometriotic cyst of ovary: report of a case.
Tian-Cheng WANG ; Bin WANG ; Juan WANG ; Xia YUAN
Chinese Journal of Pathology 2009;38(10):650-650
Adnexa Uteri
;
surgery
;
Colectomy
;
methods
;
Colonic Diseases
;
etiology
;
pathology
;
surgery
;
Colostomy
;
Endometriosis
;
complications
;
pathology
;
surgery
;
Female
;
Fistula
;
etiology
;
pathology
;
surgery
;
Follow-Up Studies
;
Humans
;
Intestinal Fistula
;
etiology
;
pathology
;
surgery
;
Middle Aged
;
Ovarian Cysts
;
complications
;
pathology
;
surgery
;
Ovarian Diseases
;
etiology
;
pathology
;
surgery
;
Ovariectomy
3.Malignant ovarian melanoma with extensive pelvic and peritoneal metastasis: a case report and literature review.
Rong GAO ; Nai-Fu LIU ; Xiu-Gui SHENG
Chinese Journal of Cancer 2010;29(4):460-462
Adnexa Uteri
;
surgery
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Diagnosis, Differential
;
Female
;
Humans
;
Melanoma
;
drug therapy
;
pathology
;
secondary
;
surgery
;
Melanosis
;
pathology
;
Middle Aged
;
Ovarian Neoplasms
;
drug therapy
;
pathology
;
surgery
;
Pelvic Neoplasms
;
secondary
;
Peritoneal Neoplasms
;
secondary
;
Teratoma
;
drug therapy
;
pathology
;
secondary
;
surgery
4.Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Jun ZHU ; Hao WEN ; Rui BI ; Xiaohua WU
Journal of Gynecologic Oncology 2016;27(2):e18-
OBJECTIVE: Uterine carcinosarcoma (UCS) shared the same staging system with endometrial carcinoma in the International Federation of Gynecology and Obstetrics 2009. The aim of the present study was to compare the clinicopathological and prognostic characteristics between UCS and grade 3 endometrioid endometrial carcinoma (G3EC). METHODS: A retrospective analysis of 60 UCS and 115 G3EC patients with initial treatment at the Department of Gynecology in the Fudan University Shanghai Cancer Center between February 2006 and August 2013. Chi-square analysis was used to compare differences between variables. Prognostic factors were determined using univariate/multivariate analysis, and the survival rates were assessed using the Kaplan-Meier method. The Cox regression model was used to assess the independent prognostic factor. RESULTS: UCS had significantly worse overall survival (OS) compared with G3EC. Carcinosarcoma subtype was an independent factor (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.0 to 5.8; p=0.039), stratified based on stage. Compared with G3EC, UCS patients had a greater incidence of ascites fluid (55.0% vs. 15.7%, p<0.001) and adnexal involvement (20.0% vs. 8.7%, p=0.048) and larger median tumor volume (4.6 cm vs. 4.0 cm, p=0.046). Subgroup analysis of the prognostic factors revealed that UCS patients exhibited worse OS than G3EC patients in such specific subgroups as patients at younger ages, with postmenopausal status, without ascites fluid, with early stage diseases, without vagina invasion, without lymph node metastases and receiving adjuvant chemo/radiotherapy. Adjuvant radiotherapy with chemotherapy was predictive of better survival in UCS patients compared with chemotherapy or radiotherapy alone (5-year OS, 71.0% vs. 35.8%, p=0.028). Multivariate Cox regression revealed that tumor mesenchymal component (HR, 4.6; 95% CI, 1.4 to 15.8; p=0.014) was an independent prognostic factor for UCS, whereas advanced stages (HR, 5.9; 95% CI, 1.0 to 33.9; p=0.046) and ascites fluid (HR, 5.1; 95% CI, 1.1 to 22.7; p=0.032) were independently correlated with poor prognosis for G3EC patients. CONCLUSION: The distinctions in both clinicopathological and prognostic characteristics between UCS and G3EC suggest that this subtype should be treated separately from high-risk epithelial endometrial carcinoma.
Adnexa Uteri/pathology
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Aorta
;
Ascites/etiology
;
Carcinoma, Endometrioid/*secondary/*therapy
;
Carcinosarcoma/*secondary/*therapy
;
Chemotherapy, Adjuvant
;
Cytoreduction Surgical Procedures
;
Endometrial Neoplasms/*pathology/*therapy
;
Female
;
Humans
;
Hysterectomy
;
*Lymph Node Excision
;
Lymphatic Metastasis
;
Middle Aged
;
Neoplasm Grading
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
Pelvis
;
Postmenopause
;
Radiotherapy, Adjuvant
;
Retrospective Studies
;
Survival Rate
;
Tumor Burden
;
Vagina/pathology
5.Clinicopathologic features of adult granulosa cell tumor including unusual morphologic variants.
Xia LIU ; Gulinar ABULAJIANG ; Ming LIU ; Wei SANG ; Yu-qing MA ; Wei ZHANG ; Wen-tao YANG
Chinese Journal of Pathology 2013;42(1):44-45
12E7 Antigen
;
Adnexa Uteri
;
surgery
;
Adult
;
Aged
;
Aged, 80 and over
;
Antigens, CD
;
metabolism
;
Cell Adhesion Molecules
;
metabolism
;
Diagnosis, Differential
;
Female
;
Follow-Up Studies
;
Granulosa Cell Tumor
;
drug therapy
;
metabolism
;
pathology
;
surgery
;
Humans
;
Hysterectomy
;
methods
;
Inhibins
;
metabolism
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Ovarian Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
surgery
;
Survival Rate
;
Vimentin
;
metabolism
6.Added Value of Using a CT Coronal Reformation to Diagnose Adnexal Torsion.
Sung Il JUNG ; Hee Sun PARK ; Younghee YIM ; Hae Jeong JEON ; Mi Hye YU ; Young Jun KIM ; Kyungah JEONG
Korean Journal of Radiology 2015;16(4):835-845
OBJECTIVE: To evaluate the increased value of using coronal reformation of a transverse computed tomography (CT) scan for detecting adnexal torsion. MATERIALS AND METHODS: This study included 106 woman suspected of having adnexal torsion who underwent CT with coronal reformations and subsequent surgical exploration. Two readers independently recorded the CT findings, such as the thickening of a fallopian tube, twisting of the adnexal pedicle, eccentric smooth wall thickening of the torsed adnexal mass, eccentric septal thickening of the torsed adnexal mass, eccentric poor enhancement of the torsed adnexal mass, uterine deviation to the twisted side, ascites or infiltration of pelvic fat, and the overall impression of adnexal torsion with a transverse scan alone or combined with coronal reformation and a transverse scan. The areas under the receiver operating characteristic curves (AUCs), sensitivity, specificity, and positive predictive value were used to compare diagnostic performance. RESULTS: Fifty-two patients were confirmed to have adnexal torsion. The addition of coronal reformations to the transverse scan improved AUCs for readers 1 and 2 from 0.74 and 0.75 to 0.92 and 0.87, respectively, for detecting adnexal torsion (p < 0.001 and p = 0.004, respectively). Sensitivity of CT for detecting twisting of the adnexal pedicle increased significantly for readers 1 and 2 from 0.27 and 0.29 with a transverse scan alone to 0.79 and 0.77 with a combined coronal reformation and a transverse scan, respectively (p < 0.001 and p < 0.001, respectively). CONCLUSION: Use of a coronal reformation with transverse CT images improves detection of adnexal torsion.
Acute Pain/diagnosis/radiography
;
Adnexa Uteri/pathology/*radiography
;
Adnexal Diseases/*radiography
;
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Area Under Curve
;
Child
;
Female
;
Humans
;
Middle Aged
;
Pelvis/radiography
;
ROC Curve
;
Retrospective Studies
;
Tomography, X-Ray Computed/*methods
;
Torsion Abnormality/*diagnosis/*radiography
;
Young Adult